Venetoclax and hypomethylating agents yield high response rates and favourable transplant outcomes in patients with newly diagnosed acute myeloid leukaemia.

Amandeep SalhotraNi-Chun TsaiJianying ZhangDat NgoAhmed AribiKaramjeet SandhuBrian BallMonzr M Al MalkiHaris AliPaul B KollerAndrew ArtzStephen FormanRyotaro NakamuraAnthony SteinGuido MarcucciIbrahim AldossVinod Pullarkat

Published in: British journal of haematology (2021)

Keyphrases

newly diagnosed
liver failure
respiratory failure
bone marrow
dendritic cells
acute myeloid leukemia
drug induced
chronic lymphocytic leukemia
hepatitis b virus
metabolic syndrome
adipose tissue
skeletal muscle
weight loss